These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15351793)

  • 1. Pharmacological characteristics of rotational behavior in hemiparkinsonian rats transplanted with mouse embryonic stem cell-derived neurons.
    Inden M; Kim D; Gu Y; Kitamura Y; Kondo J; Tsuchiya D; Taniguchi T; Shimohama S; Akaike A; Sumi S; Inoue K
    J Pharmacol Sci; 2004 Sep; 96(1):53-64. PubMed ID: 15351793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of mouse embryonic stem cell-derived neurons into the striatum, subthalamic nucleus and substantia nigra, and behavioral recovery in hemiparkinsonian rats.
    Inden M; Kim DH; Qi M; Kitamura Y; Yanagisawa D; Nishimura K; Tsuchiya D; Takata K; Hayashi K; Taniguchi T; Yoshimoto K; Shimohama S; Sumi S; Inoue K
    Neurosci Lett; 2005 Oct; 387(3):151-6. PubMed ID: 16023291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells.
    Nishimura F; Yoshikawa M; Kanda S; Nonaka M; Yokota H; Shiroi A; Nakase H; Hirabayashi H; Ouji Y; Birumachi J; Ishizaka S; Sakaki T
    Stem Cells; 2003; 21(2):171-80. PubMed ID: 12634413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.
    Mine Y; Hayashi T; Yamada M; Okano H; Kawase T
    Neurosurgery; 2009 Oct; 65(4):741-53; discussion 753. PubMed ID: 19834380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
    Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
    Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis.
    Jönsson ME; Ono Y; Björklund A; Thompson LH
    Exp Neurol; 2009 Sep; 219(1):341-54. PubMed ID: 19555687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
    Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
    J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral changes in unilaterally 6-hydroxy-dopamine lesioned rats after transplantation of differentiated mouse embryonic stem cells without morphological integration.
    Baier PC; Schindehütte J; Thinyane K; Flügge G; Fuchs E; Mansouri A; Paulus W; Gruss P; Trenkwalder C
    Stem Cells; 2004; 22(3):396-404. PubMed ID: 15153616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous intrastriatal and intranigral dopaminergic grafts in the parkinsonian rat model: role of the intranigral graft.
    Baker KA; Sadi D; Hong M; Mendez I
    J Comp Neurol; 2000 Oct; 426(1):106-16. PubMed ID: 10980486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of long-term sensorimotor recovery following intrastriatal and--accumbens DA micrografts in a rat model of Parkinson's disease.
    Falkenstein G; Rosenthal C; Reum T; Morgenstern R; Döbrössy M; Nikkhah G
    J Comp Neurol; 2009 Jul; 515(1):41-55. PubMed ID: 19399892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regenerative therapy in experimental parkinsonism: mixed population of differentiated mouse embryonic stem cells, rather than magnetically sorted and enriched dopaminergic cells provide neuroprotection.
    Tripathy D; Verma P; Nthenge-Ngumbau DN; Banerjee M; Mohanakumar KP
    CNS Neurosci Ther; 2014 Aug; 20(8):717-27. PubMed ID: 24954161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and early functional integration of dopaminergic progenitor cells following transplantation in a rat model of Parkinson's disease.
    Hahn M; Timmer M; Nikkhah G
    J Neurosci Res; 2009 Jul; 87(9):2006-19. PubMed ID: 19235889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft.
    Ferrari D; Sanchez-Pernaute R; Lee H; Studer L; Isacson O
    Eur J Neurosci; 2006 Oct; 24(7):1885-96. PubMed ID: 17067292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural precursor cells differentiated from mouse embryonic stem cells relieve symptomatic motor behavior in a rat model of Parkinson's disease.
    Xu H; Fan X; Wu X; Tang J; Yang H
    Biochem Biophys Res Commun; 2005 Jan; 326(1):115-22. PubMed ID: 15567160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antioxidant pretreatment on the survival of embryonic dopaminergic neurons in vitro and following grafting in an animal model of Parkinson's disease.
    Love RM; Branton RL; Karlsson J; Brundin P; Clarke DJ
    Cell Transplant; 2002; 11(7):653-62. PubMed ID: 12518892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C; Nikkhah G; Cunningham MG; Björklund A
    Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesencephalic neural stem (progenitor) cells develop to dopaminergic neurons more strongly in dopamine-depleted striatum than in intact striatum.
    Nishino H; Hida H; Takei N; Kumazaki M; Nakajima K; Baba H
    Exp Neurol; 2000 Jul; 164(1):209-14. PubMed ID: 10877931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonic stem cells derived neuron transplantation recovery in models of parkinsonism in relation to severity of the disorder in rats.
    Haobam R; Tripathy D; Kaidery NA; Mohanakumar KP
    Rejuvenation Res; 2015 Apr; 18(2):173-84. PubMed ID: 25546608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of recovery in the hemiparkinson rat: drug-induced rotation is inadequate.
    Castañeda E; Fleming S; Paquette MA; Boat K; Moffett J; Stachowiak EK; Bloom DC; Stachowiak MK
    Physiol Behav; 2005 Mar; 84(4):525-35. PubMed ID: 15811387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orthotopic transplantation of immortalized mesencephalic progenitors (CSM14.1 cells) into the substantia nigra of hemiparkinsonian rats induces neuronal differentiation and motoric improvement.
    Haas SJ; Petrov S; Kronenberg G; Schmitt O; Wree A
    J Anat; 2008 Jan; 212(1):19-30. PubMed ID: 18036147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.